Proton Pump Inhibitors (PPIs) and kidney disease

Millions of Americans have taken PPIs like Prilosec, Nexium and Prevacid to treat heartburn. These drugs have been promoted as a safe and more effective alternative to other antacid treatments and have been widely prescribed. These drugs, however, can allegedly cause extensive kidney damage. Numerous studies have shown the potential for injury from PPI use, and drug manufacturers have been required to add and strengthen product label warnings.

Injuries from PPI use can include acute interstitial nephritis, chronic kidney disease, end-stage renal disease, and acute kidney injuries.

In light of a substantial body of scientific evidence and a large number of adverse events, a number of cases have been filed against drug makers. Those cases have been slated to be consolidated into a Multi-District Litigation (MDL), which centralizes pretrial activities for multiple cases to save time, court costs, and attorney’s fees.

PPI brands include:

  • Aciphex (rabeprazole)
  • Dexilent/Kapidex (dexlansoprazole)
  • Nexium (esomeprazole)
  • PrevAcid (lansoprazole)
  • Prilosec (omeprazole)
  • Protonix (pantoprazole)
  • Vimovo (esomeprazole and naproxen)
  • Zegerid (omeprazole/sodium bicarbonate)

If you’ve taken one of these drugs and have suffered from kidney damage, the drug company may be liable for your injury. Fill out the form below, and an attorney will assess your case.